Quality of life and primary sclerosing cholangitis: The business of defining what counts

Hepatology. 2018 Jul;68(1):16-18. doi: 10.1002/hep.29775. Epub 2018 May 2.

Authors

Katherine Arndtz^{1

2

3}, Gideon M Hirschfield^{1

2

3}

Affiliations

¹ National Institute for Health Research Birmingham Biomedical Research Centre, Birmingham, UK.
² Institute of Immunology & Immunotherapy, University of Birmingham, Birmingham, UK.
³ Centre for Rare Diseases, Institute of Translational Medicine, Birmingham Health Partners, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham, UK.

PMID: 29315689
DOI: 10.1002/hep.29775

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Cholangitis, Sclerosing
Commerce
Humans
Patient Reported Outcome Measures*
Quality of Life*